Quick Answer
FATE THERAPEUTICS INC reported Total Assets of $318.94 million for the year ending 2025.
- FATE THERAPEUTICS INC showed a decrease of -27.6% in Total Assets from 2024 to 2025.
- This data is from FATE THERAPEUTICS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: $23.04 million | Q1 2014: $49.65 million | Q2 2014: $43.55 million | Q3 2014: $47.01 million | Q1 2015: $44.49 million | Q2 2015: $83.48 million | Q3 2015: $76.40 million | Q1 2016: $58.71 million | Q2 2016: $49.18 million | Q3 2016: $49.30 million | Q1 2017: $85.33 million | Q2 2017: $73.95 million | Q3 2017: $72.68 million | Q1 2018: $93.42 million | Q2 2018: $83.16 million | Q3 2018: $219.95 million | Q1 2019: $220.87 million | Q2 2019: $199.88 million | Q3 2019: $340.21 million | Q1 2020: $321.89 million | Q2 2020: $653.59 million | Q3 2020: $626.44 million | Q1 2021: $1.05 billion | Q2 2021: $1.02 billion | Q3 2021: $984.57 million | Q1 2022: $858.39 million | Q2 2022: $807.06 million | Q3 2022: $749.35 million | Q1 2023: $630.34 million | Q2 2023: $584.76 million | Q3 2023: $543.79 million | Q1 2024: $569.89 million | Q2 2024: $528.82 million | Q3 2024: $494.97 million | Q1 2025: $398.67 million | Q2 2025: $371.63 million | Q3 2025: $343.67 million.
- Over the full 14 years of available data (2012 to 2025), FATE THERAPEUTICS INC's Total Assets has grown by 2,779.5%.
- Historical annual values: Fiscal year 2025: $318.94 million | Fiscal year 2024: $440.69 million | Fiscal year 2023: $506.22 million | Fiscal year 2022: $705.56 million | Fiscal year 2021: $921.46 million | Fiscal year 2020: $622.46 million | Fiscal year 2019: $302.27 million | Fiscal year 2018: $213.03 million | Fiscal year 2017: $105.29 million | Fiscal year 2016: $95.05 million | Fiscal year 2015: $67.96 million | Fiscal year 2014: $51.18 million | Fiscal year 2013: $55.58 million | Fiscal year 2012: $11.08 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: